Similar Search Results

Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand

Claflin, Suzi; Campbell, Julie A.; Norman, Richard; … - In: The European journal of health economics 24 (2023) 6, pp. 939-950

Persistent link: https://www.econbiz.de/10014328151

Towards a framework for evaluating the costs and benefits of simulation modelling in healthcare

Soorapanth, Sada; Eldabi, Tillal; Young, Terry - In: Journal of the Operational Research Society 74 (2023) 3, pp. 637-646

Persistent link: https://www.econbiz.de/10014331925

The generalized risk-adjusted cost-effectiveness (GRACE) model for measuring the value of gains in health : an exact formulation

Lakdawalla, Darius; Phelps, Charles E. - In: Journal of benefit-cost analysis : JBCA 14 (2023) 1, pp. 44-67

Persistent link: https://www.econbiz.de/10014320648

An outcome evaluation of the Philippine Health Technology Assessment Program

Wong, John Q.; Co, Stephanie Anne L.; Modina, Cheyenne … - 2022

The passage of the UHC law in 2019 mandated the creation of the Health Technology Assessment (HTA) Program to identify and recommend the most cost-effective health technologies for the Philippine government to procure. Since its inception, the HTA has mostly assessed COVID-19 related...

Persistent link: https://www.econbiz.de/10014475399

The role of Iran's context for the development of health technology assessment : challenges and solutions

Behzadifar, Meysam; Behzadifar, Masoud; Saran, Maryam; … - In: Health economics review 13 (2023) 1, pp. 1-7

Health technology assessment (HTA) is a comprehensive and structured evaluation that aims to analyze the potential impacts of health technologies, including medical devices, diagnostic tools, pharmaceuticals, and public health interventions. Its purpose is to provide policymakers with...

Persistent link: https://www.econbiz.de/10014500317

Value-based clinical trials : selecting recruitment rates and trial lengths in different regulatory contexts

Alban, Andres; Chick, Stephen E.; Forster, Martin - In: Management science : journal of the Institute for … 69 (2023) 6, pp. 3516-3535

Persistent link: https://www.econbiz.de/10014305734

Networked health cooperation in the European Union : horizontal or hierarchical?

Schrama, Reini; Sindbjerg Martinsen, Dorte; … - In: Journal of common market studies : JCMS 60 (2022) 5, pp. 1488-1510

Persistent link: https://www.econbiz.de/10013392039

The dynamics of colorectal cancer management in 17 countries

Kanavos, Panos; Schurer, Willemien - In: The European Journal of Health Economics 10 (2010) 1, pp. 115-129

Persistent link: https://www.econbiz.de/10008497309

Biostatistical aspects for the use of evidence based medicine in health technology assessment

Freemantle, Nick - In: The European Journal of Health Economics 9 (2008) 1, pp. 31-43

Persistent link: https://www.econbiz.de/10005167149

The burden of rheumatoid arthritis and access to treatment: determinants of access

Lundqvist, J.; Kastäng, F.; Kobelt, G.; Jönsson, B. - In: The European Journal of Health Economics 8 (2008) 2, pp. 87-93

Persistent link: https://www.econbiz.de/10005615766